These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34833954)

  • 1. Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease.
    Hancock-Cerutti W; Millar JS; Valentini S; Liu J; Billheimer JT; Rader DJ; Cuchel M
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
    Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
    Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux.
    Chan DC; Hoang A; Barrett PH; Wong AT; Nestel PJ; Sviridov D; Watts GF
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1658-66. PubMed ID: 22745238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
    Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
    J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a rare variant in apolipoprotein A-IV, p.(V336M), and evaluation of HDL functionality in a Greek cohort with extreme HDL cholesterol levels.
    Chroni A; Rallidis L; Vassou D; Gkolfinopoulou C; Papakosta P; Zervou MI; Goulielmos GN; Kiouri E; Pappa D; Eliopoulos E; Kardassis D
    Arch Biochem Biophys; 2020 Dec; 696():108655. PubMed ID: 33130088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.
    Rached F; Santos RD; Camont L; Miname MH; Lhomme M; Dauteuille C; Lecocq S; Serrano CV; Chapman MJ; Kontush A
    J Lipid Res; 2014 Dec; 55(12):2509-20. PubMed ID: 25341944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ApoA-I truncation (ApoA-IMytilene) associated with decreased ApoA-I production.
    Anthanont P; Polisecki E; Asztalos BF; Diffenderfer MR; Barrett PH; Millar JS; Billheimer J; Cuchel M; Rader DJ; Schaefer EJ
    Atherosclerosis; 2014 Aug; 235(2):470-6. PubMed ID: 24950002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease.
    Kallend DG; Reijers JA; Bellibas SE; Bobillier A; Kempen H; Burggraaf J; Moerland M; Wijngaard PL
    Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):23-9. PubMed ID: 27418968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes.
    Costacou T; Vaisar T; Miller RG; Davidson WS; Heinecke JW; Orchard TJ; Bornfeldt KE
    J Am Heart Assoc; 2024 Jul; 13(14):e034763. PubMed ID: 38958152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of High-Density Lipoprotein Charge Heterogeneity, Cholesterol Efflux Capacity, and the Expression of High-Density Lipoprotein-Related Genes in Mononuclear Cells to the HDL-Cholesterol Level.
    Dergunov AD; Litvinov DY; Bazaeva EV; Dmitrieva VG; Nosova EV; Rozhkova AV; Dergunova LV
    Lipids; 2018 Oct; 53(10):979-991. PubMed ID: 30430582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function analysis of naturally occurring apolipoprotein A-I L144R, A164S and L178P mutants provides insight on their role on HDL levels and cardiovascular risk.
    Gkolfinopoulou C; Soukou F; Dafnis I; Kellici TF; Sanoudou D; Mavromoustakos T; Stratikos E; Chroni A
    Cell Mol Life Sci; 2021 Feb; 78(4):1523-1544. PubMed ID: 32666307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease.
    Schaefer JR; Schweer H; Ikewaki K; Stracke H; Seyberth HJ; Kaffarnik H; Maisch B; Steinmetz A
    Atherosclerosis; 1999 May; 144(1):177-84. PubMed ID: 10381291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
    Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
    Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.
    Liao D; Tan H; Hui R; Li Z; Jiang X; Gaubatz J; Yang F; Durante W; Chan L; Schafer AI; Pownall HJ; Yang X; Wang H
    Circ Res; 2006 Sep; 99(6):598-606. PubMed ID: 16931800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency.
    Marcil M; Yu L; Krimbou L; Boucher B; Oram JF; Cohn JS; Genest J
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):159-69. PubMed ID: 9888879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size.
    Brousseau ME; Eberhart GP; Dupuis J; Asztalos BF; Goldkamp AL; Schaefer EJ; Freeman MW
    J Lipid Res; 2000 Jul; 41(7):1125-35. PubMed ID: 10884295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression.
    Thorngate FE; Yancey PG; Kellner-Weibel G; Rudel LL; Rothblat GH; Williams DL
    J Lipid Res; 2003 Dec; 44(12):2331-8. PubMed ID: 12951361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events.
    Magnoni M; Andreini D; Pirillo A; Uboldi P; Latini R; Catapano AL; Maggioni AP; Norata GD;
    Ann Med; 2022 Dec; 54(1):1036-1046. PubMed ID: 35438019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients.
    Kempen HJ; Gomaraschi M; Simonelli S; Calabresi L; Moerland M; Otvos J; Jeyarajah E; Kallend D; Wijngaard PLJ
    Atherosclerosis; 2016 Dec; 255():17-24. PubMed ID: 27816804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.